vs
BALCHEM CORP（BCPC）与Forestar Group Inc.（FOR）财务数据对比。点击上方公司名可切换其他公司
Forestar Group Inc.的季度营收约是BALCHEM CORP的1.0倍（$273.0M vs $263.6M），BALCHEM CORP净利率更高（14.9% vs 5.6%，领先9.2%），BALCHEM CORP同比增速更快（9.8% vs 9.0%），过去两年BALCHEM CORP的营收复合增速更高（4.9% vs -9.6%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
BCPC vs FOR — 直观对比
营收规模更大
FOR
是对方的1.0倍
$263.6M
营收增速更快
BCPC
高出0.8%
9.0%
净利率更高
BCPC
高出9.2%
5.6%
两年增速更快
BCPC
近两年复合增速
-9.6%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $273.0M |
| 净利润 | $39.2M | $15.4M |
| 毛利率 | 35.6% | 20.1% |
| 营业利润率 | 19.8% | 7.6% |
| 净利率 | 14.9% | 5.6% |
| 营收同比 | 9.8% | 9.0% |
| 净利润同比 | 16.8% | -6.7% |
| 每股收益（稀释后） | $1.21 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCFOR
| Q4 25 | $263.6M | $273.0M | ||
| Q3 25 | $267.6M | $670.5M | ||
| Q2 25 | $255.5M | $390.5M | ||
| Q1 25 | $250.5M | $351.0M | ||
| Q4 24 | $240.0M | $250.4M | ||
| Q3 24 | $239.9M | $551.3M | ||
| Q2 24 | $234.1M | $318.4M | ||
| Q1 24 | $239.7M | $333.8M |
净利润BCPCFOR
| Q4 25 | $39.2M | $15.4M | ||
| Q3 25 | $40.3M | $86.9M | ||
| Q2 25 | $38.3M | $32.9M | ||
| Q1 25 | $37.1M | $31.6M | ||
| Q4 24 | $33.6M | $16.5M | ||
| Q3 24 | $33.8M | $81.5M | ||
| Q2 24 | $32.1M | $38.7M | ||
| Q1 24 | $29.0M | $45.0M |
毛利率BCPCFOR
| Q4 25 | 35.6% | 20.1% | ||
| Q3 25 | 35.7% | 22.3% | ||
| Q2 25 | 36.4% | 20.4% | ||
| Q1 25 | 35.2% | 22.6% | ||
| Q4 24 | 36.0% | 22.0% | ||
| Q3 24 | 35.6% | 23.9% | ||
| Q2 24 | 35.5% | 22.5% | ||
| Q1 24 | 34.0% | 24.9% |
营业利润率BCPCFOR
| Q4 25 | 19.8% | 7.6% | ||
| Q3 25 | 20.4% | 16.9% | ||
| Q2 25 | 20.1% | 11.2% | ||
| Q1 25 | 20.4% | 11.6% | ||
| Q4 24 | 19.8% | 8.7% | ||
| Q3 24 | 20.0% | 19.7% | ||
| Q2 24 | 19.6% | 16.2% | ||
| Q1 24 | 17.4% | 17.6% |
净利率BCPCFOR
| Q4 25 | 14.9% | 5.6% | ||
| Q3 25 | 15.1% | 13.0% | ||
| Q2 25 | 15.0% | 8.4% | ||
| Q1 25 | 14.8% | 9.0% | ||
| Q4 24 | 14.0% | 6.6% | ||
| Q3 24 | 14.1% | 14.8% | ||
| Q2 24 | 13.7% | 12.2% | ||
| Q1 24 | 12.1% | 13.5% |
每股收益（稀释后）BCPCFOR
| Q4 25 | $1.21 | $0.30 | ||
| Q3 25 | $1.24 | $1.70 | ||
| Q2 25 | $1.17 | $0.65 | ||
| Q1 25 | $1.13 | $0.62 | ||
| Q4 24 | $1.03 | $0.32 | ||
| Q3 24 | $1.03 | $1.59 | ||
| Q2 24 | $0.98 | $0.76 | ||
| Q1 24 | $0.89 | $0.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $211.7M |
| 总债务越低越好 | — | $793.2M |
| 股东权益账面价值 | $1.3B | $1.8B |
| 总资产 | $1.7B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.44× |
8季度趋势，按日历期对齐
现金及短期投资BCPCFOR
| Q4 25 | $74.6M | $211.7M | ||
| Q3 25 | $65.1M | $379.2M | ||
| Q2 25 | $65.4M | $189.2M | ||
| Q1 25 | $49.9M | $174.3M | ||
| Q4 24 | $49.5M | $132.0M | ||
| Q3 24 | $73.7M | $481.2M | ||
| Q2 24 | $63.7M | $359.2M | ||
| Q1 24 | $60.3M | $416.2M |
总债务BCPCFOR
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
股东权益BCPCFOR
| Q4 25 | $1.3B | $1.8B | ||
| Q3 25 | $1.3B | $1.8B | ||
| Q2 25 | $1.3B | $1.7B | ||
| Q1 25 | $1.2B | $1.6B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $1.1B | $1.5B | ||
| Q1 24 | $1.1B | $1.5B |
总资产BCPCFOR
| Q4 25 | $1.7B | $3.2B | ||
| Q3 25 | $1.7B | $3.1B | ||
| Q2 25 | $1.7B | $3.1B | ||
| Q1 25 | $1.6B | $3.0B | ||
| Q4 24 | $1.6B | $3.0B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.6B | $2.7B | ||
| Q1 24 | $1.6B | $2.6B |
负债/权益比BCPCFOR
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $-157.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-157.1M |
| 自由现金流率自由现金流/营收 | — | -57.5% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.72× | -10.19× |
| 过去12个月自由现金流最近4个季度 | — | $93.0M |
8季度趋势，按日历期对齐
经营现金流BCPCFOR
| Q4 25 | $67.3M | $-157.0M | ||
| Q3 25 | $65.6M | $256.3M | ||
| Q2 25 | $47.3M | $15.8M | ||
| Q1 25 | $36.5M | $-19.8M | ||
| Q4 24 | $52.3M | $-450.0M | ||
| Q3 24 | $51.3M | $119.2M | ||
| Q2 24 | $45.0M | $-61.7M | ||
| Q1 24 | $33.4M | $-59.2M |
自由现金流BCPCFOR
| Q4 25 | — | $-157.1M | ||
| Q3 25 | — | $255.6M | ||
| Q2 25 | — | $15.0M | ||
| Q1 25 | — | $-20.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $118.4M | ||
| Q2 24 | — | $-62.3M | ||
| Q1 24 | — | $-59.8M |
自由现金流率BCPCFOR
| Q4 25 | — | -57.5% | ||
| Q3 25 | — | 38.1% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | -5.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 21.5% | ||
| Q2 24 | — | -19.6% | ||
| Q1 24 | — | -17.9% |
资本支出强度BCPCFOR
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.2% |
现金转化率BCPCFOR
| Q4 25 | 1.72× | -10.19× | ||
| Q3 25 | 1.63× | 2.95× | ||
| Q2 25 | 1.23× | 0.48× | ||
| Q1 25 | 0.98× | -0.63× | ||
| Q4 24 | 1.56× | -27.27× | ||
| Q3 24 | 1.52× | 1.46× | ||
| Q2 24 | 1.40× | -1.59× | ||
| Q1 24 | 1.15× | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
